Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of ascending single oral doses of SAM-315, an
investigational drug, in healthy adult subjects. To obtain a preliminary pharmacokinetic (PK)
and pharmacodynamic (PD) profiles of SAM-315 in healthy subjects and to evaluate the effect
of a high-fat meal on the PK of SAM-315, an investigation drug, administered to healthy adult
subjects.